CandMig3

The CandMig3 study is trying out a preventative drug against episodic migraine. The app will make daily reporting of headache status and related conditions as easy as possible for the study participants. The app has an alarm function, so you can get reminders to fill out. Access to the headache diary is established on the first study visit.

In the app you register:

Duration and intensity of headache, headache-related symptoms, ability to function.

- Which drugs were used

- Other medical events and possible side effects

Absence from work